Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc.

NASDAQ:RIGL

Overview | Financials
Company Name Rigel Pharmaceuticals, Inc.
Symbol RIGL
Currency USD
Price 16.44
Market Cap 289,590,600
Dividend Yield 0%
52-week-range 7.48 - 29.82
Industry Biotechnology
Sector Healthcare
CEO Mr. Raul R. Rodriguez
Website https://www.rigel.com

An error occurred while fetching data.

About Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III

Related Stocks

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.542 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

4.55 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

0.351 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

1.58 USD

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.87 USD

Absci Corporation logo

Absci Corporation

ABSI

3.01 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

1.83 USD

Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc.

MNMD

7.32 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

3.87 USD

Financials

Numbers are in millions USD

Numbers are in millions USD